Evidence map›Paper›PMID 10471564›Full record

Trial reportAntimicrobial agents and chemotherapy1999

Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer.

J Carratalà, J Niubó, A Fernández-Sevilla, E Juvé, X Castellsagué, J Berlanga, J Liñares, F Gudiol

Registry-linked trialOpen access · bronzeAbstract readClinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Antimicrobial agents and chemotherapy, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00122642 (Short Daily Alcohol Locks for the Prevention of Tunneled Catheter Infection in Patients With Haematological Disease. Randomised Placebo Controlled Trial), which is not on this map. Cited by 36 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 7 pooled it
19.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00122642 phase2 / phase3completednot on this mapstarted 2005, after this paper: background citation

Short Daily Alcohol Locks for the Prevention of Tunneled Catheter Infection in Patients With Haematological Disease. Randomised Placebo Controlled Trial

TypeinterventionalSponsorErasmus Medical CenterRan2005 to 2009Enrolled440ConditionsBacteremiaArmsAlcohol-lock, placebo-lock
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 7 syntheses or guidelines pooled it, 171 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2011
    Guideline
  7. Vancomycin for prophylaxis against sepsis in preterm neonates.The Cochrane database of systematic reviews · 2000
    Pooled it
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Indian Society of Critical Care Medicine Position Statement for Central Venous Catheterization and Management 2020.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

J CarratalàInfectious Disease Service, Ciutat Sanitària i Universitària de Bellvitge, Institut Català d'Oncologia, University of Barcelona, Barcelona, Spain. jcarratala@csub.scs.es
J Niubó
A Fernández-Sevilla
E Juvé
X Castellsagué
J Berlanga
J Liñares
F Gudiol
Services Hospital · PKMicrobiology Society · GBOffice of Infectious Diseases · USInstitut Català d'Oncologia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to determine the efficacy of an antibiotic-lock technique in preventing endoluminal catheter-related infection with gram-positive bacteria in neutropenic patients with hematologic malignancies. Patients with nontunneled, multilumen central venous catheters were assigned in a randomized, double-blinded manner to receive either 10 U of heparin per ml (57 patients) or 10 U of heparin per ml and 25 microg of vancomycin per ml (60 patients), which were instilled in the catheter lumen and which were allowed to dwell in the catheter lumen for 1 h every 2 days. Insertion-site and hub swabs were taken twice weekly. The primary and secondary end points of the trial were significant colonization of the catheter hub and catheter-related bacteremia, respectively. Significant colonization of the catheter hub occurred in nine (15.8%) patients receiving heparin (seven patients were colonized with Staphylococcus epidermidis, one patient was colonized with Staphylococcus capitis, and one patient was colonized with Corynebacterium sp.), whereas the catheter hubs of none of the patients receiving heparin and vancomycin were colonized (P = 0.001). Catheter-related bacteremia developed in four (7%) patients receiving heparin (three patients had S. epidermidis bacteremia and one patient had S. capitis bacteremia), whereas none of the patients in the heparin and vancomycin group had catheter-related bacteremia (P = 0.05). The times to catheter hub colonization and to catheter-related bacteremia by the Kaplan-Meier method were longer in patients receiving heparin and vancomycin than in patients receiving heparin alone (P = 0.004 and P = 0.06, respectively). Our study shows that a solution containing heparin and vancomycin administered by using an antibiotic-lock technique effectively prevents catheter hub colonization with gram-positive bacteria and subsequent bacteremia during chemotherapy-induced neutropenia in patients with hematologic malignancy.

Indexed as

AdultAnti-Bacterial AgentsAnticoagulantsAntineoplastic AgentsBacteremiaCatheterization, Central VenousColony Count, MicrobialCorynebacteriumCorynebacterium InfectionsDouble-Blind MethodElectrophoresis, Gel, Pulsed-FieldFemaleHeparinHumansLeukemiaMaleAnti-Bacterial AgentsAnticoagulantsAntineoplastic AgentsHeparinVancomycin

Identifiers

PMID10471564
PMCPMC89446
OpenAlexW2115403775

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.